Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.
Turbine has raised €55M across 6 funding rounds from 10 investors, most recently a Series B round in Feb 2026. Based in Budapest, Hungary; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-02-25 | Series B | €21M | Beiersdorf Venture Capital,Interactive Venture Partners | View deal → |
| 2024-05-17 | Other | — | Accenture Ventures | View deal → |
| 2023-06-20 | Series A | €5.5M | MassMutual Ventures (MMV) | View deal → |
| 2022-11-22 | Series A | €20M | Accel,Day One Capital,Delin Ventures,Mercia,MSD Global Health Innovation Fund,XTX Ventures | View deal → |
| 2021-01-07 | Series A | €5.7M | Accel | View deal → |
| 2019-10-01 | Seed | €3.0M | Delin Ventures | View deal → |
